Mr. Dille leads Lygos’ finance strategy and oversees the accounting, corporate development, investor relations, tax, and treasury functions. He brings nearly 20 years of corporate finance, investment banking, and capital markets experience. Mr. Dille has a strong track record in the financing, having secured more than $500 million in both equity and debt financing before joining Lygos. He previously held senior financial positions at emerging public and private biotechnology companies, including Omada Health and TerraVia (formerly Solazyme), which was acquired by Corbion. Earlier in his career, Mr. Dille was a portfolio manager at Savitr Capital and Vice President and Senior Analyst for Clean Technology and Renewables at JMP Securities. He earned a Bachelor of Arts in Chemistry from Carleton College and is a Chartered Financial Analyst.
Current role